| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 01/07/1992 | CA1293928C Thermofiltration of plasma |
| 01/07/1992 | CA1293927C Bonding-inducing composition containing enamel matrix |
| 01/07/1992 | CA1293926C Composition for accelerating recovery of function of hematopoietic organs |
| 01/04/1992 | WO1992000767A1 Composition for stabilizing blood plasma during pasteurization |
| 01/04/1992 | CA2065284A1 Composition for stabilizing blood plasma during pasteurization |
| 01/03/1992 | WO1992000372A1 Recombinant pigeon pox virus vaccine |
| 01/03/1992 | CA2084064A1 Recombinant pigeon pox virus vaccine |
| 01/02/1992 | EP0463614A2 The use of the GM1 monosialoganglioside and of its internal ester derivative to prevent the insurgence in man of the tolerance to the analgesic effect of morphine and analogues |
| 01/02/1992 | EP0463080A1 Cd8-based pharmaceuticals |
| 01/01/1992 | CN1057393A Method for preparation of "xiaokeling" for relieving cold phlegm type bronchitis cough |
| 01/01/1992 | CN1057392A Method for preparation of calciferous medicaments |
| 01/01/1992 | CN1057386A Thermomagnetic pharmaceutical physiotherapeutic equipment |
| 12/31/1991 | US5077063 Process for preparing lactic-acid products |
| 12/31/1991 | US5077059 Proliferating established cell line from mammal, homogenizing, recovering |
| 12/31/1991 | CA1293717C Low molecular alkali huminates, process of producing same and their use |
| 12/30/1991 | CA2045982A1 Use of the gm monosialoganglioside and of its internal ester derivative to prevent the insurgence in man of the |
| 12/28/1991 | WO1991016914A1 Methods and preparations of stable, deodorized oils and pharmaceutical compositions thereof |
| 12/28/1991 | CA2082418A1 Methods and preparations of stable, deodorized oils and pharmaceutical compositions thereof |
| 12/27/1991 | EP0462721A2 Novel Bacillus thuringiensis microbes active against nematodes, and genes encoding novel nematode-active toxins cloned from Bacillus thuringiensis isolates |
| 12/27/1991 | EP0462426A1 Biocompatible perforated membranes and their use as artificial skin |
| 12/27/1991 | EP0462291A1 Acat enzyme inhibiting composition |
| 12/27/1991 | EP0462246A1 Oligomeric immunoglobulins |
| 12/27/1991 | EP0462215A1 MOLECULAR CLONING OF GENOMIC AND cDNA SEQUENCES ENCODING CELLULAR RECEPTORS FOR POLIOVIRUS |
| 12/27/1991 | EP0462177A1 Purified insulin mediators and purification process for same |
| 12/26/1991 | WO1991019510A1 Osteoinductive pharmaceutical formulations |
| 12/26/1991 | WO1991019509A1 Protein a and polypeptide of its molecule for the treatment of tumors |
| 12/26/1991 | WO1991019501A1 Intercellular adhesion mediators |
| 12/25/1991 | CN1057296A Process for producing lactobacillinum |
| 12/24/1991 | US5075320 Method and composition for treating parasitic infestation of animals |
| 12/24/1991 | US5075112 Administering fine powder as antitumor agent |
| 12/23/1991 | WO1992000096A1 Vaccine composition for treating human chlamydial diseases |
| 12/23/1991 | CA2065320A1 Vaccine composition for treatment of human ailments due to chlamydiae |
| 12/20/1991 | WO1991019507A1 Chinese herbal extracts in the treatment of hiv related disease |
| 12/20/1991 | CA2064743A1 Chinese herbal extracts in the treatment of hiv related disease |
| 12/19/1991 | WO1991019736A2 Cancer-associated scm-recognition factor, preparation and method of use |
| 12/19/1991 | CA2084767A1 Cancer-associated scm-recognition factor, preparation and method of use |
| 12/18/1991 | EP0462022A2 Anti-diabetic agents and veterinary anti-diabetic agents |
| 12/18/1991 | EP0462021A2 Cholesterol-lowering agents and veterinary cholesterol-lowering agents |
| 12/18/1991 | EP0462020A2 Anti-herpes agents and veterinary anti-herpes agent |
| 12/18/1991 | EP0461799A2 Bacillus thuringiensis isolate having anti-protozoan activity |
| 12/17/1991 | US5073373 Flowable demineralized bone powder composition and its use in bone repair |
| 12/17/1991 | US5073367 Administering Bacillus IP 5832 |
| 12/17/1991 | CA1293214C Process for the preparation of a factor v concentrate |
| 12/17/1991 | CA1293190C Antiviral immunotherapeutic agent and preparation thereof |
| 12/16/1991 | WO1991019506A1 Human bone marrow derived suppressor factor |
| 12/16/1991 | WO1991019502A1 Intercellular adhesion mediators |
| 12/16/1991 | CA2085352A1 Human bone marrow derived suppressor factor |
| 12/16/1991 | CA2084888A1 Intercellular adhesion mediators |
| 12/16/1991 | CA2044808A1 Anti-diabetic agents and veterinary anti-diabetic agents |
| 12/16/1991 | CA2044802A1 Anti-herpes agents and veterinary anti-herpes agents |
| 12/15/1991 | WO1991019718A1 Reveromycin a, production thereof, and antitumor drug and fungicide |
| 12/12/1991 | WO1991018972A1 Culturing bone marrow cells for adoptive immunotherapy |
| 12/12/1991 | WO1991018620A1 Stimulation of bone marrow stromal and progenitor cells |
| 12/12/1991 | WO1991018616A1 Composite molecular system for the contra-escalatory treatment of viral infections |
| 12/12/1991 | CA2042868A1 Bacillus thuringiensis microbes active against nematodes, and genes encoding novel nematode-active toxins cloned from bacillus thuringiensis isolates |
| 12/11/1991 | EP0460480A2 Bacterin for the treatment of necrophorum diseases and a method for the production thereof |
| 12/11/1991 | EP0460058A1 Use of bactericidal/permeability increasing protein or biologically active analogs thereof for the manufacture of a medicament to treat endotoxin-associated disorders |
| 12/11/1991 | EP0260315B1 Separation and method of use of density specific blood cells |
| 12/11/1991 | CN1056813A Therapeutic composition containing phenol compound and propolis, wich is useful against lipid capsid viruses, especially herpes |
| 12/10/1991 | US5071961 Adsorption on alpha-hydroxyaminopropyl-modified adsorber, then elution |
| 12/10/1991 | US5071958 Removal of soft tissue; application of a low molecular weight protein fraction of enamel matrix; joining with living mineralized tissue |
| 12/10/1991 | US5071655 Pharmaceutical combination for treatment of bone-wasting diseases |
| 12/07/1991 | WO1991018617A1 Immunostimulant drug based on polar glycopeptidolipids of mycobacterium chelonae |
| 12/04/1991 | EP0458965A1 Process for the preparation of vinyl ethers. |
| 12/04/1991 | EP0458911A1 ENDOTHELIAL CELL-LEUKOCYTE ADHESION MOLECULES (ELAMs) AND MOLECULES INVOLVED IN LEUKOCYTE ADHESION (MILAs) |
| 12/04/1991 | EP0425593A4 Irradiation of blood products |
| 12/04/1991 | EP0308456B1 Compositon for the treatment of the epiderm |
| 12/04/1991 | CN1056633A Manufacturing method of tissue nourishing liquid |
| 12/04/1991 | CN1056632A Apparatus preparing concentrate of coagulation factors, such as fibrinogen, from blood sample |
| 12/04/1991 | CN1056631A Making method of medicines treating foot diseases (including corn) |
| 12/03/1991 | US5070076 Polypeptide mixture; immunostimulant; side effect reduction; n onallergenic |
| 12/03/1991 | US5069912 Method of treating spastic colitis |
| 12/03/1991 | CA1292691C Method for the effective treatment of disease conditions in humans associated with htl virus infection |
| 11/28/1991 | WO1991018089A1 Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome |
| 11/28/1991 | WO1991017809A1 Venting system |
| 11/28/1991 | WO1991017778A1 An apparatus for preparing a concentrate of coagulation factors, such as fibrinogen, from a blood sample |
| 11/28/1991 | WO1991017766A1 Remedy for asthma |
| 11/28/1991 | WO1991017758A1 Germ cell and/or amphibian embryo extracts, a method for obtaining them and their use in cosmetic and/or dermatological compositions |
| 11/28/1991 | WO1991017674A1 White laver |
| 11/27/1991 | EP0457950A1 Use of stearidonic acid in the treatment of inflammatory disorders |
| 11/27/1991 | EP0457856A1 Isolation growth and differentiation of human muscle cells |
| 11/27/1991 | EP0349593B1 Method of producing high aqueous volume multilamellar vesicles |
| 11/27/1991 | EP0201574B1 A preparation for the treatment of hemophilia a inhibitor patients and a process for producing such a preparation |
| 11/27/1991 | CN1014859B Process for extracting anti-carcinogen from snake tail in 16-26 cm segment |
| 11/26/1991 | WO1991018615A1 Human peripheral blood cells in an immunocompromised host |
| 11/26/1991 | WO1991018504A1 Process for lyophilizing cells, cell-like materials and platelets in a mixture of biocompatible amphipathic polymers |
| 11/26/1991 | CA2064075A1 Human peripheral blood cells in an immunocompromised host |
| 11/26/1991 | CA2062941A1 Process for lyophilizing cells, cell-like materials and platelets in a mixture of biocompatable amphipathic polymers |
| 11/21/1991 | EP0457196A2 Photodynamic inactivation of viruses in cell-containing compositions |
| 11/21/1991 | EP0457183A1 Device and its use in the separation of plasma from blood |
| 11/20/1991 | CN1056240A Inhibition nf allograft and concordant xenograft rejection |
| 11/20/1991 | CN1056239A Process to prepare accelerator from silkworm chrysalis for silkworm to resist diseases and spin-out more silk |
| 11/19/1991 | US5066788 Do not inhibit thrombin |
| 11/19/1991 | US5066787 Blood coagulation inhibiting proteins, processes for preparing them and their uses |
| 11/19/1991 | US5066593 Synthetic peptide-based anti-rabies compositions and methods |
| 11/19/1991 | US5066496 Composition and method for treatment of gastric and duodenal ulcers and mucosal erosions |
| 11/18/1991 | WO1991017655A1 Novel lyophilized and reconstituted cell compositions |
| 11/15/1991 | WO1991017738A1 Color modified melanins and methods for their preparation and use |
| 11/14/1991 | WO1991017268A1 T-cell receptor variable transcripts as disease related markers |
| 11/14/1991 | WO1991017188A1 Separation of mammalian semen into fractions enriched either for spermatozoa containing an x chromosome or for spermatozoa contai ning a y chromosome |